EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Dual-Target Inhibitors for Epidermal Growth Factor Receptor and AKT: Virtual Screening Based on Structure and Molecular Dynamics Study

Hanyu Yang, Zhiwei Zhang iD, Qian Liu, Jie Yu, Chongjin Liu, Wencai Lu

Molecules · 2023

DOI: 10.3390/molecules28227607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Hanyu Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Physics, Qingdao University, Qingdao 266071, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wencai Lu, Natural Science Foundation of Shandong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermal growth factor EGFR is an important target for non-small cell lung (NSCL) cancer, and inhibitors of the AKT protein have been used in many cancer treatments, including those for NSCL cancer. Therefore, searching small molecular inhibitors which can target both EGFR and AKT may help cancer treatment. In this study, we applied a ligand-based pharmacophore model, molecular docking, and MD simulation methods to search for potential inhibitors of EGFR and then studied dual-target inhibitors of EGFR and AKT by screening the immune-oncology Chinese medicine (TCMIO) database and the human endogenous database (HMDB). It was found that TCMIO89212, TCMIO90156, and TCMIO98874 had large binding free energies with EGFR and AKT, and HMDB0012243 also has the ability to bind to EGFR and AKT. These results may provide valuable information for further experimental study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCarcinoma, Non-Small-Cell LungLung NeoplasmsHumansMolecular Dynamics SimulationMolecular Docking SimulationProto-Oncogene Proteins c-aktProtein Kinase InhibitorsErbB Receptors

Stichwörter der Autor:innen

AKTEGFRHMDBTCMIOsmall molecule inhibitors

Substanzen

Antineoplastic AgentsProto-Oncogene Proteins c-aktProtein Kinase InhibitorsErbB Receptors

Autor:innen und Institutionen

  • College of Physics, Qingdao University, Qingdao 266071, China.
  • School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.

ORCID-Profile: Zhiwei Zhang

Förderung

  • Wencai Lu
  • Natural Science Foundation of Shandong Province of China

Zitieren

APA

Yang, H., Zhang, Z., Liu, Q., Yu, J., Liu, C., & Lu, W. (2023). Identification of Dual-Target Inhibitors for Epidermal Growth Factor Receptor and AKT: Virtual Screening Based on Structure and Molecular Dynamics Study. Molecules. https://doi.org/10.3390/molecules28227607

Vancouver

Yang H, Zhang Z, Liu Q, Yu J, Liu C, Lu W. Identification of Dual-Target Inhibitors for Epidermal Growth Factor Receptor and AKT: Virtual Screening Based on Structure and Molecular Dynamics Study. Molecules. 2023. doi:10.3390/molecules28227607

BibTeX
@article{Yang2023,
  author = {Yang, Hanyu and Zhang, Zhiwei and Liu, Qian and Yu, Jie and Liu, Chongjin and Lu, Wencai},
  title = {Identification of Dual-Target Inhibitors for Epidermal Growth Factor Receptor and AKT: Virtual Screening Based on Structure and Molecular Dynamics Study},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28227607}
}
Kostenlos starten →